CT
Menu
Search
Sections
Home
News
Analysis
Features
Comment & Opinion
Projects
Data Insights
Sectors
Clinical Trials
Approvals
Operations
Outsourced Services
Supply Chain
Data Management
Medical Devices
Themes
Artificial Intelligence
Cloud
Corporate Governance
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Insights
Deals
Jobs
Filings
Patents
Social Media
Companies
Company A-Z
Company Categories
Product & Services
Company Releases
White Papers
Videos
Buyer's Guides
Partner Content
Events
Reports
Premium Insights
Excellence Awards
Innovation Rankings
Magazine
Newsletters
GlobalData
About Us
Advertise With Us
Contact Us
Our Marketing Solution
GlobalData Reports
Visit GlobalData
From Our Partners
Optimizing Cell & Gene Therapy Processes
Accelerating Clinical Trials
Improving decentralized trials with mobile research nursing
The new era of global patient recruitment
The next chapter of clinical trial services
Trusted clinical trial packaging services
News
Analysis
Sections
Features
Comment & Opinion
Projects
Data Insights
Latest
Pipeline Moves: Pfizer’s flu vaccine approval chances rise after Phase III completion
Clinical Trials In Oncology West Coast 2024: Patient experience front and centre
Pipeline Moves: Progression prospects for stuttering candidate increase after trial completion
Sectors
Sections
Clinical Trials
Approvals
Operations
Outsourced Services
Supply Chain
Data Management
Medical Devices
Latest
gaitQ and machineMD secure $1m to kickstart Parkinson’s movement study
Artiva doses first subject in Phase I lupus nephritis treatment trial
Roche’s OCREVUS SC shows promise in Phase III multiple sclerosis trial
Themes
Sections
Artificial Intelligence
Cloud
Corporate Governance
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Foreign Direct Investment
Latest
Hyperfine starts enrolment in portable imaging workflow study
Ultimovacs downsizes to funnel funds to cancer vaccine programme
Repatha for the Treatment of Heterozygous and Homozygous Familial Hypercholesterolaemia, US
Insights
Sections
Deals
Jobs
Filings
Patents
Social Media
Latest
Q4 2023 update: M&A activity in pharmaceutical in China
How did M&A perform in pharmaceutical in Q4 2023?
Q4 2023 update: M&A activity in pharmaceutical in the US
Companies
Sections
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer's Guides
Partner Content
Latest
Leading cybersecurity companies in clinical trials
Harnessing the power of cell and gene therapy in oncology
IT and bioinformatics companies for the clinical trials industry
Events
Buy Reports
Newsletters
CT
CRC GamaMabs Pharma Lonsurf
GamaMabs Pharma doses first patient in Phase ll trial of GM102
Sign up for our daily news round-up!
Give your business an edge with our leading industry insights.
Sign up
View more
